Amneal Pharmaceuticals Inc. Earnings

Amneal Pharmaceuticals Inc.’s revenue jumped 3.24% since last year same period to $724.51Mn in the Q2 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 4.18% jump in its revenue since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit jumped 273.99% since last year same period to $22.42Mn in the Q2 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 83.82% jump in its net profits since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit margin jumped 262.26% since last year same period to 3.09% in the Q2 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 76.44% jump in its net profit margins since last 3-months.

Amneal Pharmaceuticals Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 938.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a -7.35% fall from last quarter’s estimates.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.16.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Amneal Pharmaceuticals Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.